The Medi-Globe Group will in cooperation with the French Institut Hospitalo-Universitaire (IHU) Strasbourg develop the world’s first AI software for the detection of diseases of the pancreas in endoscopic ultrasound (EUS) examination. The key technology here is artificial intelligence. As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications.
Markus Schönberger, Director of Business Development of the Medi-Globe Group:
„With the AI software, in the future we will be able to provide gastroenterologists with a virtual expert and give them the opportunity to significantly improve the diagnostics that determine therapy. Very good results have already been achieved in the first clinical applications. Small lesions were detected, even in complex cases. This gives the treating physicians and, above all, the patients great hope for improvement of patient care in the medium term“.
Marc Jablonowski, CTIO of the Medi-Globe Group:
“We cooperate very closely with the leading international university hospitals. With the help of artificial intelligence, we, together with the researchers at the IHU, will be able to make the clinical experience of the world’s leading gastroenterologists available to all doctors in the future. In doing so, we are consistently expanding our role as an innovation leader in minimally invasive diagnostics and therapy“.
